A detailed history of Rafferty Asset Management, LLC transactions in Organon & Co. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 21,433 shares of OGN stock, worth $327,496. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,433
Previous 19,768 8.42%
Holding current value
$327,496
Previous $409,000 0.24%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$18.65 - $23.03 $31,052 - $38,344
1,665 Added 8.42%
21,433 $410,000
Q2 2024

Aug 13, 2024

SELL
$17.45 - $21.96 $134,801 - $169,641
-7,725 Reduced 28.1%
19,768 $409,000
Q1 2024

May 13, 2024

SELL
$13.78 - $18.8 $133,335 - $181,908
-9,676 Reduced 26.03%
27,493 $516,000
Q4 2023

Feb 13, 2024

SELL
$10.95 - $17.32 $93,753 - $148,293
-8,562 Reduced 18.72%
37,169 $535,000
Q3 2023

Nov 13, 2023

BUY
$16.59 - $23.77 $106,159 - $152,104
6,399 Added 16.27%
45,731 $793,000
Q2 2023

Aug 11, 2023

BUY
$19.27 - $24.63 $95,540 - $122,115
4,958 Added 14.42%
39,332 $818,000
Q1 2023

May 11, 2023

BUY
$21.42 - $32.08 $34,014 - $50,943
1,588 Added 4.84%
34,374 $808,000
Q4 2022

Feb 13, 2023

BUY
$23.31 - $28.61 $254,918 - $312,878
10,936 Added 50.05%
32,786 $916,000
Q3 2022

Nov 14, 2022

BUY
$23.4 - $34.25 $210,880 - $308,661
9,012 Added 70.2%
21,850 $511,000
Q2 2022

Aug 12, 2022

SELL
$31.66 - $38.9 $224,817 - $276,228
-7,101 Reduced 35.61%
12,838 $433,000
Q1 2022

May 13, 2022

SELL
$30.45 - $39.36 $570,054 - $736,858
-18,721 Reduced 48.42%
19,939 $696,000
Q4 2021

Feb 10, 2022

BUY
$28.67 - $37.13 $228,155 - $295,480
7,958 Added 25.92%
38,660 $1.18 Million
Q3 2021

Nov 10, 2021

BUY
$28.63 - $35.64 $680,420 - $847,020
23,766 Added 342.65%
30,702 $1.01 Million
Q2 2021

Aug 10, 2021

BUY
$28.45 - $38.0 $197,329 - $263,568
6,936 New
6,936 $210,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.